2006
         Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study. Circulation. 2006;113(25):2897-905.  
           Promising pharmacologic innovations in treating pulmonary fibrosis. Curr Opin Pharmacol. 2006;6(3):284-92.  
           GR 63799X, an EP3 receptor agonist, induced S phase arrest and 3T6 fibroblast growth inhibition. Eur J Pharmacol. 2006;529(1-3):16-23.  
           Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases. Appl Immunohistochem Mol Morphol. 2006;14(2):208-16.  
           The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep. 2006;7(1):114-9.  
           Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies. Biochem Biophys Res Commun. 2006;348(2):628-36.  
           Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res. 2006;66(18):9017-25.  
           Cell signaling and function organized by PB1 domain interactions. Mol Cell. 2006;23(5):631-40.  
           Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother. 2006;58(6):1198-207.  
   
          